Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 131

Results For "disease"

2358 News Found

Global pacemakers market set to grow at 5.4% CAGR over next 3 years: GlobalData
News | December 12, 2022

Global pacemakers market set to grow at 5.4% CAGR over next 3 years: GlobalData

GlobalData predicts the average prices of dual chamber pacemakers in both India and China are expected to reduce at an average CAGR of -3.42% from 2022 to 2025.


Govt to celebrate Universal Health Coverage Day 2022
News | December 09, 2022

Govt to celebrate Universal Health Coverage Day 2022

Anandiben Patel, Governor, Uttar Pradesh will inaugurate the two-day celebrations


Emmes launches Cell and Gene Therapy Center
News | December 09, 2022

Emmes launches Cell and Gene Therapy Center

The new center will focus on supporting the clinical trials clients who are developing cell and gene therapies


Takeda’s dengue vaccine QDENGA approved for use in EU
Drug Approval | December 09, 2022

Takeda’s dengue vaccine QDENGA approved for use in EU

The approval follows the positive recommendation from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) in October 2022


BASF and MedAccess complete shipment of 35 million interceptor G2 nets to fight malaria
Healthcare | December 09, 2022

BASF and MedAccess complete shipment of 35 million interceptor G2 nets to fight malaria

35 million mosquito nets supplied to countries in sub-Saharan Africa through partners


ASG Eye Hospitals opens hospital in Vashi
Healthcare | December 06, 2022

ASG Eye Hospitals opens hospital in Vashi

The new eye hospital in Vashi is ASG’s second in the Mumbai Metropolitan Region (MMR) and the sixth in Maharashtra


EMA accepts marketing authorisation application for momelotinib for the treatment of myelofibrosis
News | December 05, 2022

EMA accepts marketing authorisation application for momelotinib for the treatment of myelofibrosis

Application includes data from key phase III trials, including the pivotal MOMENTUM trial, which met all primary and key secondary efficacy endpoints


SRL Diagnostics launches laboratory in Shimla
Clinical Trials | December 01, 2022

SRL Diagnostics launches laboratory in Shimla

The laboratory has the capacity to conduct 30,000+ tests in a month ranging from simple routine tests to semi-specialized and specialized tests


Akums partners with Leiutis and Biophore for developing products for multiple therapies
News | December 01, 2022

Akums partners with Leiutis and Biophore for developing products for multiple therapies

The focus of the companies in this partnership is to synergise capabilities, leverage research and bring innovative products in specific therapeutic areas


AstraZeneca’s Dapagliflozin receives CDSCO approval
Drug Approval | November 30, 2022

AstraZeneca’s Dapagliflozin receives CDSCO approval

Dapagliflozin reduces the risk of sustained eGFR, cardiovascular deaths and hospitalization for heart failure in adults with CKD